Negedia was founded in 2019, from over 30 years of Telethon Foundation experience in rare genetic diseases; the company is dedicated to researchers and laboratories and is able to offer innovative solutions that provide immediate answers for research and diagnosis.
Negedia focuses on understanding an individual’s genetic and molecular characteristics to make informed decisions about prevention, wellness and treatment.
Negedia's products provide accurate and complete results designed to assist the clinician in the diagnostic process and patient management. This is why Negedia is constantly working on the creation and optimization of NGS-based diagnostic solutions, to provide affordable, complete, timely and trustworthy genetic tests based on NGS.